Indeed a very interesting group of people on the Phillippines zoom conference last night.
I suspect that results from the unusual nature of the conference call.
The conference call was apparently attended primarily by Phillippine physicians who are presumably open to the possibility of requesting LL for their paitients.
Really the only physician who asked a question was Dr. Dennis Serrano who appears to be the principal kidney transplant physician in Manila, Phillippines. He is the cheif of this and that for at least four hospital programs in Manila. One of which is St. Luke's hospital in Manila.
My suspicion is that Dr. Serrano has some leadership power in the Philllippine medical community.
The conference call was organized by someone from St Lukes hospital in Manila.
It could be that the conference call was organized primarily for an audience of one: Dr. Dennis Serrano.
Another interesting fact is that Dr. Serrano would not be a treating physician for leronlimab because he is a surgeon. He does transplants, including lots of kidney transplants, and then hands of the patient to hospital doctors whom he referred to as "intensivists".
The main reason Seethamraju and Agresti were on the call is because they are as close as possible to peer-to-peer for Dr. Serrano.
Dr. Serrano's questions was: What is the roadmap?
Dr. Serrano appeared to be unaware that no Phillippine physcian has requested a CSP for leronlimab.
So now he's on the call, he realizes no one has yet requested CSP, and he essentially wonders why out loud. And asks about schedule and delivery. And he learns that the next CSP will be the first.
When Dr. Francis, an employee of Chiral, answers Dr. Serrano's question on when will a patient be treated, Dr. Francis says we need a CSP request from a physician and the physician's patient.
Probably Dr. Serrano has never done a CSP before.
Dr. Francis says the Phillippine FDA will process CSPs much faster than other apps.
Dr. Serrano, still thinking out loud, doubts that CSP will be effected as fast as Dr. Agresti describes the EIND process in the US: 3-4 days from US FDA request to patient injection.
So surely Pourhassan and Chiral's Dr. Francis can see the wheels turning in Dr. Serrano's head.
Hopefully Pourhassan and Francis have already worked out the pricing.
Now Pourhassan and Chiral see Serrano's concern that LL is not really shippable to Phillippines.
Probably Pourhassan will overnite 5000 or so vials to Chiral as a result of this call?
Maybe Dr. Serrano is the bigwig. He is not going to treat any patients with LL. But all of the at least four hospitals that he works at in Manila may be willing to follow his lead.
If Francis obtains a local supply as the result of the call, Francis can inform Serrano that only now waiting for a physician to request a CSP.
Does Francis have a line at the government to get CSPs turned around in 8 hours? Dr. Serrano is certainly going to be wondering about that.
So maybe the Manila-area Serrano affiliated hospitals, of which I think there are at least four, could move fast if CYDY puts some product in Chiral's Phillipine located refrigerators.
Is Serrano's leadership enough to move any other hospitals in the Philippines?
Chiral's Dr. Francis probably still has a problem on the pricing.
Maybe Pourhassan has told him $1000 per vial to CYDY. Maybe Francis has to negotiate the rest with the Phillippine hospitals.
Enough loose ends here that any action they take will certainly not be before CD12 reports. And since the CD12 report is so close, then they will probably wait. Although maybe they decide the early bird gets the worm.
I suspect that results from the unusual nature of the conference call.
The conference call was apparently attended primarily by Phillippine physicians who are presumably open to the possibility of requesting LL for their paitients.
Really the only physician who asked a question was Dr. Dennis Serrano who appears to be the principal kidney transplant physician in Manila, Phillippines. He is the cheif of this and that for at least four hospital programs in Manila. One of which is St. Luke's hospital in Manila.
My suspicion is that Dr. Serrano has some leadership power in the Philllippine medical community.
The conference call was organized by someone from St Lukes hospital in Manila.
It could be that the conference call was organized primarily for an audience of one: Dr. Dennis Serrano.
Another interesting fact is that Dr. Serrano would not be a treating physician for leronlimab because he is a surgeon. He does transplants, including lots of kidney transplants, and then hands of the patient to hospital doctors whom he referred to as "intensivists".
The main reason Seethamraju and Agresti were on the call is because they are as close as possible to peer-to-peer for Dr. Serrano.
Dr. Serrano's questions was: What is the roadmap?
Dr. Serrano appeared to be unaware that no Phillippine physcian has requested a CSP for leronlimab.
So now he's on the call, he realizes no one has yet requested CSP, and he essentially wonders why out loud. And asks about schedule and delivery. And he learns that the next CSP will be the first.
When Dr. Francis, an employee of Chiral, answers Dr. Serrano's question on when will a patient be treated, Dr. Francis says we need a CSP request from a physician and the physician's patient.
Probably Dr. Serrano has never done a CSP before.
Dr. Francis says the Phillippine FDA will process CSPs much faster than other apps.
Dr. Serrano, still thinking out loud, doubts that CSP will be effected as fast as Dr. Agresti describes the EIND process in the US: 3-4 days from US FDA request to patient injection.
So surely Pourhassan and Chiral's Dr. Francis can see the wheels turning in Dr. Serrano's head.
Hopefully Pourhassan and Francis have already worked out the pricing.
Now Pourhassan and Chiral see Serrano's concern that LL is not really shippable to Phillippines.
Probably Pourhassan will overnite 5000 or so vials to Chiral as a result of this call?
Maybe Dr. Serrano is the bigwig. He is not going to treat any patients with LL. But all of the at least four hospitals that he works at in Manila may be willing to follow his lead.
If Francis obtains a local supply as the result of the call, Francis can inform Serrano that only now waiting for a physician to request a CSP.
Does Francis have a line at the government to get CSPs turned around in 8 hours? Dr. Serrano is certainly going to be wondering about that.
So maybe the Manila-area Serrano affiliated hospitals, of which I think there are at least four, could move fast if CYDY puts some product in Chiral's Phillipine located refrigerators.
Is Serrano's leadership enough to move any other hospitals in the Philippines?
Chiral's Dr. Francis probably still has a problem on the pricing.
Maybe Pourhassan has told him $1000 per vial to CYDY. Maybe Francis has to negotiate the rest with the Phillippine hospitals.
Enough loose ends here that any action they take will certainly not be before CD12 reports. And since the CD12 report is so close, then they will probably wait. Although maybe they decide the early bird gets the worm.
10
